Novo Nordisk’s shares fell sharply on Monday after the results from testing the Danish company’s CagriSema drug fell short of investors’ expectations.
The so-called fit checks have begun at Ramsey Group Practice in the north of the island, as part of a project that could also help to shape future services.
，详情可参考爱思助手下载最新版本
Информации о пострадавших в результате происшествия не поступало.
2026-02-26 00:00:00:03014223310http://paper.people.com.cn/rmrb/pc/content/202602/26/content_30142233.htmlhttp://paper.people.com.cn/rmrb/pad/content/202602/26/content_30142233.html11921 中华人民共和国和德意志联邦共和国联合新闻声明